Merck Company Stock Alpha and Beta Analysis

MRK Stock  USD 125.23  0.14  0.11%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Merck Company. It also helps investors analyze the systematic and unsystematic risks associated with investing in Merck over a specified time horizon. Remember, high Merck's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Merck's market risk premium analysis include:
Beta
0.85
Alpha
0.0392
Risk
1.1
Sharpe Ratio
0.0844
Expected Return
0.0925
Please note that although Merck alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., NYSE Composite index.) So in this particular case, Merck did 0.04  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Merck Company stock's relative risk over its benchmark. Merck Company has a beta of 0.85  . As returns on the market increase, Merck's returns are expected to increase less than the market. However, during the bear market, the loss of holding Merck is expected to be smaller as well. At this time, Merck's Book Value Per Share is quite stable compared to the past year. Enterprise Value Over EBITDA is expected to rise to 46.87 this year, although Price Fair Value will most likely fall to 6.91.

Merck Quarterly Cash And Equivalents

8.61 Billion

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Merck Backtesting, Merck Valuation, Merck Correlation, Merck Hype Analysis, Merck Volatility, Merck History and analyze Merck Performance.

Merck Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Merck market risk premium is the additional return an investor will receive from holding Merck long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Merck. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Merck's performance over market.
α0.04   β0.85

Merck expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Merck's Buy-and-hold return. Our buy-and-hold chart shows how Merck performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Merck Market Price Analysis

Market price analysis indicators help investors to evaluate how Merck stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Merck shares will generate the highest return on investment. By understating and applying Merck stock market price indicators, traders can identify Merck position entry and exit signals to maximize returns.

Merck Return and Market Media

The median price of Merck for the period between Sat, Jan 20, 2024 and Fri, Apr 19, 2024 is 125.31 with a coefficient of variation of 2.86. The daily time series for the period is distributed with a sample standard deviation of 3.56, arithmetic mean of 124.44, and mean deviation of 2.9. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Merck Rises Higher Than Market Key Facts
03/28/2024
2
Merck Stock Sinks As Market Gains What You Should Know
04/03/2024
 
Merck dividend paid on 5th of April 2024
04/05/2024
3
PureTech Launches Seaport Therapeutics with 100 Million Oversubscribed Series A and Announces Management Transitions
04/09/2024
4
Moderna Up 6 percent on Upbeat Data From Cancer Jab Study
04/10/2024
5
Merck Co., Inc.s Stock Financial Prospects Look Bleak Should Shareholders Be Prepared For A Share Price Correction
04/11/2024
6
The Global Market for Insomnia Trends, Forecasts, and Competitive Analysis to 2030 Featuring Vanda Pharma, Neurim, Eisai, Purdue Pharma, Merck, Pfizer, Astellas...
04/12/2024
7
Dermocosmetics Skin Care Products Market to surpss 98.33 billion by 2031, booming at a CAGR of 8.1 percent Report by Coherent Market Insights
04/15/2024
8
Johnson Johnson Q1 2024 Earnings Call Transcript
04/16/2024
9
Disposition of 6224 shares by Smart Dalton of Merck at 117.89 subject to Rule 16b-3
04/18/2024

About Merck Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Merck or other stocks. Alpha measures the amount that position in Merck Company has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2022 2023 2024 (projected)
Dividend Yield0.0250.02690.0246
Price To Sales Ratio4.744.624.3

Merck Upcoming Company Events

As portrayed in its financial statements, the presentation of Merck's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Merck's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Merck's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Merck. Please utilize our Beneish M Score to check the likelihood of Merck's management manipulating its earnings.
25th of April 2024
Upcoming Quarterly Report
View
6th of August 2024
Next Financial Report
View
31st of March 2024
Next Fiscal Quarter End
View
6th of February 2025
Next Fiscal Year End
View
31st of December 2023
Last Quarter Report
View
31st of December 2023
Last Financial Announcement
View

Build Portfolio with Merck

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Merck Company is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Merck Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Merck Company Stock. Highlighted below are key reports to facilitate an investment decision about Merck Company Stock:

Complementary Tools for Merck Stock analysis

When running Merck's price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.
Commodity Directory
Find actively traded commodities issued by global exchanges
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bonds Directory
Find actively traded corporate debentures issued by US companies
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
CEOs Directory
Screen CEOs from public companies around the world
Merck technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Merck technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Merck trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...